Croup (laryngotracheobronchitis) is a common manifestation tives of this study were to describe the epidemiologic features and temporal trends of croup hospitalizations in the United of lower respiratory tract illness in children. It is a syndrome associated with inflammation and obstruction of the larynx and States and to determine the proportion of croup hospitalizations attributable to HPIV-1 by using the unique temporal pattern of trachea and is characterized clinically by inspiratory stridor, barking cough, and hoarseness. Most cases occur within the HPIV-1 activity. first 3 years of life, with the greatest incidence in the second Methods year of life; at this age, 1% -5% of children may require outpaCroup hospitalization data for 1979 through 1993 were obtained tient evaluation for croup [1 -4] . Croup accounts for 10% -from the National Hospital Discharge Survey (NHDS) compiled 35% of lower respiratory tract illness seen in pediatric practice by the National Center for Health Statistics (NCHS), Centers for [2, 3, 5] . The proportion of children hospitalized ranges from Disease Control and Prevention (CDC) [20, 21] . The NHDS con-1.3% to 5.6% of croup cases seen in pediatric practices [2 -4] sists of a nationally representative probability sample of patient to 31% of croup cases seen in a pediatric emergency room [5] . United States, and the virus is infrequently detected during the §15 years of age (0.7%) and records with unstated ages (1.5%).
intervening periods [2, 16 -19] . Overall hospitalization rates and those by 5-year age group were calculated using the census population for the respective years and are presented per 100,000 children [20, 21, 23] . Rates for infants and 1-year-old children were estimated using natality data [24] . children õ15 years of age (rate, 77.0). Croup was the first-58.6). Assuming that the 1.6-fold difference in total croup hospitalizations between odd-and even-numbered years is due listed diagnosis in 83.3% of hospital discharge records and the only listed diagnosis in 45.0% of records. The most common solely to HPIV-1 activity, then 18,000 (22.5%) croup hospitalizations were attributable to HPIV-1 during each biennium, diagnoses listed with croup were unspecified otitis media (15.6%), unspecified pneumonia (7.3%), unspecified viral inand 36.7% of croup hospitalizations were attributable to HPIV-1 during odd-numbered years. fection (6.2%), unspecified acute bronchitis (4.2%), and bronchiolitis (3.4%). Croup was recorded in 3.9% of hospitaliza-
The seasonal trends in croup hospitalizations were age-dependent. For children õ5 years of age, croup hospitalizations tions for respiratory illness (ICD-9-CM 460 -519) and 0.6% of all hospitalizations among children õ15 years of age.
reflected the overall seasonal pattern, with major peaks in October and minor peaks around February (figure 2), and the annual Children õ5 years of age accounted for 90.9% of croup hospitalizations (rate, 205.0). Hospitalization rates were 19.2/100,000/ hospitalization rate was 252.6/100,000 in odd-numbered years compared with 150.7/100,000 in even-numbered years. For year for 5-to 9-year-olds and 2.2/100,000 children per year for 10-to 14-year-olds. The percentage of croup hospitalizations was children §5 years old, the annual winter peak was similar in magnitude to the autumn peak and there was no apparent inhighest for infants õ1 year of age (29.4%; rate, 311.5) and 1-year-old children (31.8%; rate, 341.8) and then decreased markcrease in the magnitude of the autumn peak during odd-numbered years. edly with increasing age. Among infants, the number of hospitalizations increased ú6-fold from the first to the fifth month of life, When we compared the first 3 years of the 15-year study period with the final 3 years, we identified a 18.5% decline in when it plateaued. The crude case-fatality rate for infants õ1 year of age was 0.2% and for 1-year-old children was 0.1%. No deaths croup hospitalizations during the study period and a 22.0% decline in hospitalizations from all causes for children õ15 were recorded for children §2 years of age.
For children õ5 years old, the hospitalization rate for boys years old. The median duration of hospitalization was 2.0 days (mean, 2.8), and it decreased from 3.0 days (mean, 3.2) in the was 1.9 times greater than that for girls (boys, 267.1; girls, 140.0). The elevated male-to-female rate ratio did not change first 3 years of the study period to 2.0 days (mean, 2.4) in the last 3 years. The median duration of hospital stay decreased with increasing age: it was 3.2 among 5-to 9-year-old children and 2.5 among 10-to 14-year-old children. Information on race from 3.0 days (mean, 3.3) among infants õ1 year of age to 2.0 days (mean, 2.2) among children 4 years of age and was was available in 86.5% of records; 74.1% of patients were white (rate, 70.5), 9.1% were black (rate, 46.3), and the re-2.0 days (mean, 2.8) among children 5 -14 years of age. maining 3.3% (rate, 63.4) were recorded as ''other.'' Two seasonal trends in croup hospitalizations were observed. Discussion Major peaks occurred biennially during October in odd-numbered years, and minor peaks occurred annually around FebruDuring the 15-year study period, we observed major peaks in croup hospitalizations in October of odd-numbered years ary (figure 1). The timing of the major peaks in the autumn of odd-numbered years coincided with periods of peak HPIV-1 that are best explained by HPIV-1 infection. In the United States, HPIV-1 has produced biennial epidemics of acute respiactivity nationally. The mean number of croup hospitalizations in odd-numbered years was 49,000 (rate, 93.0) compared with ratory illness in autumn of odd-numbered years since 1973, and this distinctive temporal pattern of HPIV-1 activity is coina mean of 31,000 hospitalizations in even-numbered years (rate, / 9d3b$$de09
10-29-97 17:53:03 jinfal UC: J Infect cident with the major peaks in croup hospitalizations that we 1 to be the most common etiologic agent identified in croup cases. HPIV-2 is likely to be the second most important contribobserved. In addition, our estimate that 22.5% of all croup hospitalizations per biennium and 36.7% of hospitalizations utor to the autumn peak each year [5, 18, 19] . The minor peaks of croup hospitalizations around February during odd-numbered years can be attributed to HPIV-1 falls within the range expected from previous etiologic studies of annually are most likely attributable to influenza virus and respiratory syncytial virus. While respiratory syncytial virus is croup (table 1). These studies have consistently shown HPIV- / 9d3b$$de09
10-29-97 17:53:03 jinfal UC: J Infect most important in children õ5 years of age, influenza virus ization rate of 1.3% for patients seen in a pediatric practice [2] and 31% for patients seen in a pediatric emergency room [5] , would be expected to be a more common cause of croup in we estimate that there will be 3,077,000 provider contacts and children §5 years old [2, 15, 25] .
129,000 emergency room (ER) visits for croup each year. Using In children §5 years old, there was no evidence of an HPIVan average of 18,000 HPIV-1 -associated croup hospitaliza-1 -specific increase in croup hospitalizations because the oddtions every other year, we estimate that there are 1,385,000 and even-numbered year peaks in autumn were of similar clinic visits and 58,000 ER visits every other year attributable magnitude. Although other studies have demonstrated that to HPIV-1. Extrapolation from our study provides an estimate HPIV-1 continues to be a cause of croup among older children of 77,000 croup-associated ER visits during the autumn of an that requires outpatient treatment [2] , its relative importance odd-numbered year, which is 30% lower than a previous estias a cause of croup hospitalization decreases with age [1] . mate of ER visits for croup [5] . This decrease in rate of hospitalization with increasing age Hospitalization for croup was more common among boys corresponds to an increase in the seroprevalence of antibodies than girls. The magnitude of the difference, a 1.9-fold increase to HPIV-1 [26, 27] , suggesting that other etiologic agents asin boys compared with girls for children õ5 years of age, is sume greater importance as the cause of croup in older hospitalcomparable to that reported by others [2, 3, 5, 30] . However, ized children.
we also found that boys §5 years old had higher hospitalization This study provides a population-based estimate of hospitalrates than girls, and several previous studies have reported that izations derived from a nationally representative probability incidence of croup becomes similar by gender with increasing sample. We found 49,000 croup hospitalizations in years when age [2, 30] . The factors underlying these gender differences HPIV-1 is active and 31,000 in years when HPIV-1 is not are not understood [31, 32] . active. During autumn epidemics in odd-numbered years, Among infants õ1 year of age, the numbers of hospitaliza-HPIV-1 may account for 18,000 (36.7%) croup hospitalizations for croup increased steadily between birth and the fifth tions. Our estimate for HPIV-1 -associated hospitalizations is month of life. This finding is consistent with maternally aclower than the estimate by Henrickson et al. [5] of 28,000 -quired antibodies protecting infants during the first months of 33,000 croup hospitalizations nationally for autumn 1991.
life [26, 27, 33] . Their study provided estimates of HPIV-1 -and HPIV-2 -assoOur analysis shows a decline in croup hospitalizations and ciated hospitalizations in the United States based on a study in hospitalizations from all causes for children õ15 years of conducted in Milwaukee from mid-September 1991 to midage. This decline may represent changing criteria for pediatric December 1991. During the 3-month interval beginning midhospital admission aimed at decreasing health care costs [34] . September, we estimate that there were 24,000 hospitalizations
The temporal change in hospitalizations makes it difficult to from all causes during odd-numbered years and 8000 during use these data to assess long-term trends in morbidity due to even-numbered years. Their higher estimates result in part from HPIV-1. inclusion of HPIV-2 hospitalizations during a year in which Several limitations need to be considered for NHDS-based high levels of HPIV-2 activity occurred in that community.
estimates. First, sensitivity and specificity for identifying croup Although HPIV-2 usually plays a minor role in croup hospitalhospitalizations have not been independently validated. Howizations compared with HPIV-1 [7, 9] , HPIV-2 activity can ever, the clinical presentation of croup, with inspiratory stridor, vary from year to year in a community [2, 16 -18] , and in barking cough, and hoarseness, is so striking that it may be less some instances may be a more important cause of croup hospisubject to misclassification bias than other clinically defined talization [5, 28, 29] .
syndromes. Second, the sample includes only 0.5% of all hospiOur data suggest that croup is associated with significant talizations and does not include federal institutions, such as health care costs. If we apply the number of croup hospitalizaIndian Health Service hospitals, which do provide pediatric tions in odd-and even-numbered years (49,000/year vs. 31,000/ care [20] . Third, changes in the NHDS sampling design in year), the mean hospital stay during the last 3 years of our 1988 [20] may affect comparisons between earlier and later study (2.4 days), and the mean costs of hospitalization ($619/ years. We would not expect these limitations to have a major day) from the Milwaukee study [5] , then croup hospitalizations impact on our results. cost an estimated $73,000,000 during HPIV-1 epidemic years In summary, our data, based on a nationally representative and $46,000,000 during nonepidemic years, for an estimated probability sample of hospitalizations, provide estimates of discost of $27,000,000 every other year for HPIV-1 -associated ease burden that are similar to and complement previous estihospitalizations. Our estimate for total croup hospitalization mates [5] based on extrapolations from community hospitalizacosts during the autumn of an odd-numbered year is tions. Together, these data convincingly demonstrate the $36,000,000, or 82% of the $44,000,000 for the cost of croup significant public health impact of HPIV-1 epidemics. hospitalizations estimated in the Milwaukee study [5] . Our lower estimate probably reflects the impact of high HPIV-2
